Scandinavian Enalapril Survival Study (CONSENSUS) N Engl J Med 1987;316(23):1429–1435 364 Garg R, Yusuf S Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure Collaborative Group on ACE Inhibitor Trials JAMA 1995;273(18):1450–1456 365 Goldstein S, Hjalmarson A The mortality effect of metoprolol CR/XL in patients with heart failure: results of the MERIT-HF trial Clin Cardiol 1999;22(suppl 5):V30–V35 366 McMurray JJ, Packer M, Desai AS, et al Angiotensin-neprilysin inhibition versus enalapril in heart failure N Engl J Med 2014;371(11):993–1004 367 Newman TJ, Maskin CS, Dennick LG, et al Effects of captopril on survival in patients with heart failure Am J Med 1988;84(3a):140–144 368 Packer M, Bristow MR, Cohn JN, et al The effect of carvedilol on morbidity and mortality in patients with chronic heart failure U.S Carvedilol Heart Failure Study Group N Engl J Med 1996;334(21):1349–1355 369 Pitt B, Zannad F, Remme WJ, et al The effect of spironolactone on morbidity and mortality in patients with severe heart failure Randomized Aldactone Evaluation Study investigators N Engl J Med 1999;341(10):709–717 370 SOLVD Investigators, Yusuf S, Pitt B, et al Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions N Engl J Med 1992;327(10):685–691 371 Yancy CW, Jessup M, Bozkurt B, et al 2016 ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Failure society of America J Am Coll Cardiol 2016;68(13):1476– 1488 372 Yancy CW, Jessup M, Bozkurt B, et al 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Failure Society of America J Am Coll Cardiol 2017;70(6):776–803 373 Yancy CW, Jessup M, Bozkurt B, et al 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines Circulation 2013;128(16):e240–e327 374 Frazier OH, Gregoric ID, Messner GN Total circulatory support with an LVAD in an adolescent with a previous Fontan procedure Tex Heart Inst J 2005;32(3):402–404 375 Deshpande SR, Dalal A, Kim DW, Babaliaros V, Jokhadar M Acute embolic myocardial infarction and heart failure in a Fontan patient: recovery with impella device and successful transplantation ASAIO J 2016;62(6):e52–e54 376 Mitchell MB, Campbell DN, Ivy D, et al Evidence of pulmonary vascular disease after heart transplantation for Fontan circulation failure J Thorac Cardiovasc Surg 2004;128(5):693–702 377 Kavarana MN, Jones JA, Stroud RE, et al Pulmonary arteriovenous malformations after the superior cavopulmonary shunt: mechanisms and clinical implications Expert Rev Cardiovasc Ther 2014;12(6):703–713 378 Zardi EM, Abbate A, Zardi DM, et al Cirrhotic cardiomyopathy J Am Coll Cardiol 2010;56(7):539–549 379 Cobden I, Shore A, Wilkinson R, Record CO ... update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/ American Heart Association task force on clinical practice guidelines and the Heart Failure society of... ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/ American Heart Association task force on clinical practice guidelines and the Heart Failure Society of America... 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines Circulation 2013;128(16):e240–e327